148 related articles for article (PubMed ID: 31270118)
1. Individual mortality information in the German Pharmacoepidemiological Research Database (GePaRD): a validation study using a record linkage with a large cancer registry.
Langner I; Ohlmeier C; Zeeb H; Haug U; Riedel O
BMJ Open; 2019 Jul; 9(7):e028223. PubMed ID: 31270118
[TBL] [Abstract][Full Text] [Related]
2. Validating mortality in the German Pharmacoepidemiological Research Database (GePaRD) against a mortality registry.
Ohlmeier C; Langner I; Garbe E; Riedel O
Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):778-84. PubMed ID: 27061445
[TBL] [Abstract][Full Text] [Related]
3. Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study.
Ohlmeier C; Langner I; Hillebrand K; Schmedt N; Mikolajczyk R; Riedel O; Garbe E
BMC Public Health; 2015 Jun; 15():570. PubMed ID: 26087768
[TBL] [Abstract][Full Text] [Related]
4. Implementation of an algorithm for the identification of breast cancer deaths in German health insurance claims data: a validation study based on a record linkage with administrative mortality data.
Langner I; Ohlmeier C; Haug U; Hense HW; Czwikla J; Zeeb H
BMJ Open; 2019 Jul; 9(7):e026834. PubMed ID: 31350240
[TBL] [Abstract][Full Text] [Related]
5. Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database.
Garbe E; Suling M; Kloss S; Lindemann C; Schmid U
Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):258-64. PubMed ID: 21351307
[TBL] [Abstract][Full Text] [Related]
6. [Linkage of claims data with data from epidemiological cancer registries: possibilities and limitations in the German federal states].
Pigeot I; Bongaerts B; Eberle A; Katalinic A; Kieschke J; Luttmann S; Meyer M; Nennecke A; Rathmann W; Stabenow R; Wilsdorf-Köhler H; Kollhorst B; Reinders T
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 May; 65(5):615-623. PubMed ID: 34940893
[TBL] [Abstract][Full Text] [Related]
7. [Enrichment of Claims Data with Official Causes of Death Using a Record Linkage with the Epidemiological Cancer Registry of North Rhine-Westphalia: Feasibility Study and Comparison of Procedures].
Langner I; Krieg V; Heidinger O; Hense HW; Zeeb H
Gesundheitswesen; 2019 Aug; 81(8-09):629-635. PubMed ID: 29390198
[TBL] [Abstract][Full Text] [Related]
8. Record linkage of claims and cancer registries data-Evaluation of a deterministic linkage approach based on indirect personal identifiers.
Kollhorst B; Reinders T; Grill S; Eberle A; Intemann T; Kieschke J; Meyer M; Nennecke A; Rathmann W; Pigeot I
Pharmacoepidemiol Drug Saf; 2022 Dec; 31(12):1287-1293. PubMed ID: 36129372
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of pregnancy outcome records in the German Pharmacoepidemiological Research Database (GePaRD).
Mikolajczyk RT; Kraut AA; Garbe E
Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):873-80. PubMed ID: 23733705
[TBL] [Abstract][Full Text] [Related]
10. Incidence of advanced colorectal cancer in Germany: comparing claims data and cancer registry data.
Oppelt KA; Luttmann S; Kraywinkel K; Haug U
BMC Med Res Methodol; 2019 Jul; 19(1):142. PubMed ID: 31286896
[TBL] [Abstract][Full Text] [Related]
11. Record linkage for pharmacoepidemiological studies in cancer patients.
Herk-Sukel MP; Lemmens VE; Poll-Franse LV; Herings RM; Coebergh JW
Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):94-103. PubMed ID: 21812067
[TBL] [Abstract][Full Text] [Related]
12. [Cohort study of cancer incidence in patients with type 2 diabetes: record linkage of encrypted data from an external cohort with data from the epidemiological Cancer Registry of North Rhine-Westphalia].
Kajüter H; Geier AS; Wellmann I; Krieg V; Fricke R; Heidinger O; Hense HW
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):52-9. PubMed ID: 24357173
[TBL] [Abstract][Full Text] [Related]
13. A comparison of accuracy and computational feasibility of two record linkage algorithms in retrieving vital status information from HIV/AIDS patients registered in Brazilian public databases.
de Paula AA; Pires DF; Filho PA; de Lemos KRV; Barçante E; Pacheco AG
Int J Med Inform; 2018 Jun; 114():45-51. PubMed ID: 29673602
[TBL] [Abstract][Full Text] [Related]
14. Optimizing an algorithm for the identification and classification of pregnancy outcomes in German claims data.
Wentzell N; Schink T; Haug U; Ulrich S; Niemeyer M; Mikolajczyk R
Pharmacoepidemiol Drug Saf; 2018 Sep; 27(9):1005-1010. PubMed ID: 30022557
[TBL] [Abstract][Full Text] [Related]
15. The Nordic countries as a cohort for pharmacoepidemiological research.
Furu K; Wettermark B; Andersen M; Martikainen JE; Almarsdottir AB; Sørensen HT
Basic Clin Pharmacol Toxicol; 2010 Feb; 106(2):86-94. PubMed ID: 19961477
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the impact of the mammography screening program on breast cancer mortality: feasibility study on linking several data sources in North Rhine-Westphalia].
Fuhs A; Bartholomäus S; Heidinger O; Hense HW
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):60-7. PubMed ID: 24357174
[TBL] [Abstract][Full Text] [Related]
17. [Linkage of secondary data with cancer registry data on the basis of encrypted personal identifiers - results from a pilot study in North Rhine-Westphalia].
Kajüter H; Batzler WU; Krieg V; Heidinger O; Hense HW
Gesundheitswesen; 2012 Aug; 74(8-9):e84-9. PubMed ID: 22836935
[TBL] [Abstract][Full Text] [Related]
18. [Secondary Data for Pharmacoepidemiological Research - Making the Best of It!].
Pigeot I; Kollhorst B; Didelez V
Gesundheitswesen; 2021 Nov; 83(S 02):S69-S76. PubMed ID: 34695869
[TBL] [Abstract][Full Text] [Related]
19. Validity and representativeness of the "Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies.
Becher H; Kostev K; Schröder-Bernhardi D
Int J Clin Pharmacol Ther; 2009 Oct; 47(10):617-26. PubMed ID: 19825325
[TBL] [Abstract][Full Text] [Related]
20. Linkage of routinely collected oncology clinical data with health insurance claims data--an example with aromatase inhibitors, tamoxifen, and all-cause mortality.
Dore DD; Liang C; Ziyadeh N; Norman H; Bayliss M; Seeger JD
Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2():29-36. PubMed ID: 22552977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
